当前位置:首页 - 行情中心 - 海尔生物(688139) - 财务分析 - 现金流量表

海尔生物

(688139)

  

流通市值:110.65亿  总市值:110.65亿
流通股本:3.18亿   总股本:3.18亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,681,571,829.291,156,363,413.19553,238,068.822,331,426,426.33
  收到的税费返还28,202,468.0324,623,824.358,890,451.8936,631,224.75
  收到其他与经营活动有关的现金49,860,321.2918,378,285.0718,575,983.3661,228,597.93
  经营活动现金流入小计1,759,634,618.611,199,365,522.61580,704,504.072,429,286,249.01
  购买商品、接受劳务支付的现金880,864,392.6650,033,142.42265,382,591.231,159,181,659.06
  支付给职工以及为职工支付的现金481,731,863.06333,363,699.84182,109,920.34573,465,500.65
  支付的各项税费101,364,948.8571,377,311.1535,877,317.22140,800,365.81
  支付其他与经营活动有关的现金213,030,277.78108,951,302.4460,115,473.74264,171,805.23
  经营活动现金流出小计1,676,991,482.291,163,725,455.85543,485,302.532,137,619,330.75
  经营活动产生的现金流量净额82,643,136.3235,640,066.7637,219,201.54291,666,918.26
二、投资活动产生的现金流量:
  收回投资收到的现金3,139,860,0002,279,900,0001,102,900,0002,964,720,441.37
  取得投资收益收到的现金17,124,148.9113,120,658.216,637,955.2316,107,763.43
  处置固定资产、无形资产和其他长期资产收回的现金净额358,28090,338.23-819,713.89
  投资活动现金流入小计3,157,342,428.912,293,110,996.441,109,537,955.232,981,647,918.69
  购建固定资产、无形资产和其他长期资产支付的现金80,869,727.0968,398,152.1228,103,424.73126,704,812.78
  投资支付的现金2,944,800,0002,175,569,771.63954,000,0003,485,754,092
  取得子公司及其他营业单位支付的现金56,647,50047,647,50045,000,000160,405,720.83
  投资活动现金流出小计3,082,317,227.092,291,615,423.751,027,103,424.733,772,864,625.61
  投资活动产生的现金流量净额75,025,201.821,495,572.6982,434,530.5-791,216,706.92
三、筹资活动产生的现金流量:
  吸收投资收到的现金---4,465,172.8
  其中:子公司吸收少数股东投资收到的现金---4,465,172.8
  取得借款收到的现金20,000,00020,000,00015,000,00010,000,000
  收到其他与筹资活动有关的现金538,303,291.65358,868,861.1179,362,611.12179,520,750
  筹资活动现金流入小计558,303,291.65378,868,861.1194,362,611.12193,985,922.8
  偿还债务支付的现金10,000,00010,000,0005,000,00018,588,206.82
  分配股利、利润或偿付利息支付的现金148,510,068.41148,454,174.72136,486.11163,930,252.88
  其中:子公司支付给少数股东的股利、利润---840,481.61
  支付其他与筹资活动有关的现金645,325,067.21435,948,901.54207,394,777.29238,294,737.54
  筹资活动现金流出小计803,835,135.62594,403,076.26212,531,263.4420,813,197.24
  筹资活动产生的现金流量净额-245,531,843.97-215,534,215.16-18,168,652.28-226,827,274.44
四、汇率变动对现金及现金等价物的影响1,655,825.715,555,997.041,204,511.814,434,529.58
五、现金及现金等价物净增加额-86,207,680.12-172,842,578.67102,689,591.57-721,942,533.52
  加:期初现金及现金等价物余额534,704,030.68534,704,030.68534,704,030.681,256,646,564.2
  期末现金及现金等价物余额448,496,350.56361,861,452.01637,393,622.25534,704,030.68
补充资料:
  净利润-147,213,041.4-381,008,045.8
  资产减值准备-2,932,521.61-2,756,186.74
  固定资产和投资性房地产折旧-35,622,434.12-70,389,400.37
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-35,238,111.62-69,620,755.37
    投资性房地产折旧-384,322.5-768,645
  无形资产摊销-24,164,032.34-45,738,498.63
  长期待摊费用摊销-1,145,098.75-1,841,795.77
  递延收益摊销--1,631,822.66--7,696,411.04
  处置固定资产、无形资产和其他长期资产的损失-18,792.77--233,571.76
  固定资产报废损失-171,159.07-1,864,142.84
  公允价值变动损失--1,894,977.61--5,468,787.54
  财务费用--13,611,814.62--12,156,302.68
  投资损失--15,907,644.87--23,794,761.37
  递延所得税--13,314,357.87--19,479,822.9
  其中:递延所得税资产减少--10,199,357.76--14,084,705.66
    递延所得税负债增加--3,115,000.11--5,395,117.24
  存货的减少-29,355,937.96--68,722,067.41
  经营性应收项目的减少--95,632,254.5--173,735,221.4
  经营性应付项目的增加--79,564,536.38-76,510,475.64
  现金的期末余额-361,861,452.01-534,704,030.68
  减:现金的期初余额-534,704,030.68-1,256,646,564.2
  现金及现金等价物的净增加额--172,842,578.67--721,942,533.52
公告日期2025-10-312025-08-272025-04-302025-03-29
审计意见(境内)标准无保留意见
TOP↑